Proteomics

Dataset Information

0

Immunopeptidome of HeLa-CIITA cells silenced for TAX1BP1(T6BP) expression


ABSTRACT: CD4+ T lymphocytes play a major role in the establishment and maintenance of immunity. They are activated by antigenic peptides derived from extracellular or newly synthesized (endogenous) proteins presented on the surface of antigen presenting cells (APCs) by the MHC-II molecules. The pathways leading to endogenous MHC-II presentation remain poorly characterized. We demonstrate here that the autophagy receptor, T6BP, influences both autophagy-dependent and -independent endogenous presentation of HIV- and HCMV-derived peptides. By studying the immunopeptidome of MHC-II molecules, we show that T6BP affects both the quantity and quality of peptides presented. T6BP silencing induces mislocalization of the MHC-II-loading compartments and a rapid degradation of the invariant chain (CD74) without altering the expression and internalization kinetics of MHC-II molecules. T6BP also controls the ER localization of the chaperone calnexin that we identified as a T6BP partner. Remarkably, calnexin silencing in APCs replicates the functional consequences of T6BP silencing: decreased CD4+ T cell activation and exacerbated CD74 degradation. Altogether, we unravel T6BP as a key player of the MHC-II-restricted endogenous presentation pathway and we propose one potential mechanism of action.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell

SUBMITTER: Arnaud Moris  

LAB HEAD: Arnaud Moris

PROVIDER: PXD024417 | Pride | 2022-09-22

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Hela_Mock1_Tue39_replicate1.msf Msf
Hela_Mock1_Tue39_replicate1.raw Raw
Hela_Mock1_Tue39_replicate2.msf Msf
Hela_Mock1_Tue39_replicate2.raw Raw
Hela_Mock1_Tue39_replicate3.msf Msf
Items per page:
1 - 5 of 81

Similar Datasets

2024-11-08 | PXD054248 | Pride
2022-05-31 | PXD033935 | Pride
2017-11-02 | PXD007635 | Pride
2018-12-11 | PXD010450 | Pride
2018-03-01 | PXD008937 | Pride
2022-07-19 | PXD035324 | Pride
2019-12-11 | PXD015947 | Pride
2020-12-01 | PXD019258 | Pride
2023-03-11 | PXD037955 | Pride
2023-07-05 | PXD041804 | Pride